checkAd

    EQS-Adhoc  538  0 Kommentare Cytos Biotechnology AG invites to the Annual General Meeting


    EQS Group-Ad-hoc: Cytos Biotechnology AG / Key word(s): AGM/EGM
    Cytos Biotechnology AG invites to the Annual General Meeting

    08.06.2015 / 07:00
    Release of an ad hoc announcement pursuant to Art. 53 KR.
    The issuer is solely responsible for the content of this announcement.

    ---------------------------------------------------------------------

    Cytos Biotechnology Ltd. invites to the Annual General Meeting

    Schlieren (Zurich), Switzerland, June 8, 2015 - Cytos Biotechnology Ltd
    ("Cytos") today announced that the Annual General Meeting 2015 will take
    place on Monday, June 29, 2015 at 11 a.m. at Cytos' offices in
    Schlieren/Zurich (Switzerland).

    The formal invitation to the meeting will be sent out within the next few
    days and can also be downloaded from the following website:

    http://www.cytos.com/uploads/2015/AGM2015.pdf

    For further information, please contact:

    Cytos Biotechnology Ltd
    Harry Welten, MBA
    Chief Financial Officer
    Tel: +41 44 733 46 46
    harry.welten@cytos.com

    About Cytos Biotechnology Ltd

    Cytos is a public biopharmaceutical company located in Schlieren (Zurich),
    Switzerland. The Company is listed according to the Main Standard on the
    SIX Swiss Exchange Ltd under the symbol CYTN.

    Forward Looking Statements
    This media release contains certain forward-looking statements that involve
    risks and uncertainties that could cause actual results to be materially
    different from historical results or from any future results expressed or
    implied by such forward-looking statements. You are urged to consider
    statements that include the words "will" or "expect" or the negative of
    those words or other similar words to be uncertain and forward-looking.
    Factors that may cause actual results to differ materially from any future
    results expressed or implied by any forward-looking statements include
    scientific, business, economic and financial factors, Against the
    background of these uncertainties, readers should not rely on
    forward-looking statements. The Company assumes no responsibility for
    updating forward-looking statements or adapting them to future events or
    developments.

    www.cytos.com

    End of ad hoc announcement

    +++++
    Additional features:

    Document: http://n.equitystory.com/c/fncls.ssp?u=UXLSRJPYGR
    Document title: Cytos_AGM2015

    ---------------------------------------------------------------------

    08.06.2015 News transmitted by EQS Schweiz AG. www.eqs.com - news
    archive: http://switzerland.eqs.com/de/News

    The issuer is responsible for the contents of the release.

    ---------------------------------------------------------------------


    Language: English
    Company: Cytos Biotechnology AG
    Wagistr. 25
    8952 Schlieren
    Switzerland
    Phone: +41 44 733 4747
    Fax: +41 44 733 4740
    E-mail: info@cytos.com
    Internet: www.cytos.com
    ISIN: CH0011025217, CH0029060735
    Valor: -
    Listed: Regulated Unofficial Market in Berlin, Munich, Stuttgart;
    Open Market in Frankfurt ; SIX


    End of News EQS Group News-Service
    ---------------------------------------------------------------------
    365761 08.06.2015


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-Adhoc Cytos Biotechnology AG invites to the Annual General Meeting EQS Group-Ad-hoc: Cytos Biotechnology AG / Key word(s): AGM/EGM Cytos Biotechnology AG invites to the Annual General Meeting 08.06.2015 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the …